Financhill
Back

BioVie 10K Form

Sell
30

BIVI
BioVie

Last Price:
3.06
Seasonality Move:
13.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive BIVI News And Ratings

See the #1 stock for the next 7 days that we like better than BIVI

BIVI Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-3.58M
Price / Cash Flow: 0
Annual Sales: $1.77
Price / Book: 3.93

Profitability

EPS (TTM): -5.20000
Net Income (TTM): $-25.56M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

BioVie Earnings Forecast

Key BioVie Financial Ratios

  • The Interest Expense is -9.01% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

BioVie Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BIVI
Website: bioviepharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIVI Technical Analysis vs Fundamental Analysis

Sell
30
BioVie (BIVI) is a Sell

Is BioVie a Buy or a Sell?

  • BioVie stock is rated a Sell
    The current BioVie [BIVI] share price is $3.11. The Score for BIVI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.